Harbour Investments, Inc. Novo Cure LTD Transaction History

Harbour Investments, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$40.29 - $82.51 $4,029 - $8,251	-100 Reduced 68.03%	47 $1,000
Q1 2023 May 15, 2023	SELL	$56.44 - $118.81 $169 - $356	-3 Reduced 2.0%	147 $8,000
Q4 2022 Feb 15, 2023	BUY	$63.98 - $85.37 $255 - $341	4 Added 2.74%	150 $11,000
Q4 2021 Feb 16, 2022	SELL	$75.08 - $121.99 $32,584 - $52,943	-434 Reduced 74.83%	146 $11,000
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $3,833 - $6,420	33 Added 6.03%	580 $67,000
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $10,432 - $18,046	80 Added 17.13%	547 $121,000
Q1 2021 Aug 17, 2021	BUY	$124.11 - $190.17 $57,959 - $88,809	467 New	467 $62,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.